A 5-year interim analysis of the PERCEIVE real-world study showed sustained improvement of light sensitivity in patients ...

Initial favorable safety profile demonstrated in OPGx-BEST1 clinical trialRESEARCH TRIANGLE PARK, N.C., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Opus Genetics (Nasdaq: IRD) (“Opus Genetics” or the “Company”) ...

Moolooloo station, nestled in South Australia's Flinders Ranges, might look like your typical outback farm, but the workforce ...

I moved into curriculum leadership in my second year of teaching, then into pastoral leadership, and later became Acting ...

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

Multimodal imaging, including OCT and FAF, is crucial for differentiating between AMD and IRDs, enabling precise diagnosis.

Visually impaired sportsman Gavin Kilpatrick is helping to grow competitive disabled fishing in SA, while inspiring others ...

Visually impaired sportsman Gavin Kilpatrick is helping to grow competitive disabled fishing in SA, while inspiring others ...

MALVERN, Pa., Dec. 10, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr ...

To make an accurate diagnosis and initiate the correct treatment, geographic atrophy (GA) must be differentiated from similar diseases. The presence of well-defined lesions is the most distinct ...

Researchers at the University of Geneva, together with colleagues in Switzerland, France, the United States and Israel, ...